CSL – the star performer in manufacturing
Analysis by Peter Roberts Blood and vaccine product company CSL (ASX: CSL) is living proof that manufacturing can not only prosper from an Australian base, but can find support among Australian investors. The company along with medical device makers, Cochlear and ResMed, stands alone in an investment landscape that otherwise is patchy in its support…
Details